The cost of the vaccine against the coronavirus, which is being developed by the American company Moderna, may be about 50-60 dollars for the course. This publication reports the Financial Times, citing sources close to negotiations with potential buyers.
It is noted that such a price may be fixed for sales of the vaccine in the country and also export in countries with a high income. However, other companies which are also engaged in the development of the drug, estimated the value of their product cheaper. In particular, Pfizer and BioNTtech called the price at 19.5 dollars per dose, and AstraZeneca — three or four dollars.
According to one of the sources, named Moderna the cost makes it difficult to negotiate the purchase of the product, as other manufacturers have promised much lower prices. It is assumed that at the moment it is not final.
Previously, Moderna announced that it has initiated the third phase of clinical trials of the drug. They are attended by 30 thousand volunteers. The US President Donald trump made the possibility of us exports vaccine against the coronavirus to other countries.
Video, photo All from Russia.